Risk factor convergence in the development of lacunar strokes and vascular cognitive impairment and dementia
腔隙性中风、血管性认知障碍和痴呆发生的危险因素趋同
基本信息
- 批准号:10043409
- 负责人:
- 金额:$ 41.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAdhesivesAffectAgingAlzheimer&aposs DiseaseAnimal FeedAnimal ModelBehavioralBlood - brain barrier anatomyCerebral small vessel diseaseCerebrumCessation of lifeDataDementiaDependenceDepositionDevelopmentDiabetes MellitusDietDoseElderlyEtiologyEvolutionExcisionFructoseGliosisHistologicHumanHyperhomocysteinemiaHypertensionImaging TechniquesImmunohistochemistryImpaired cognitionInbred SHR RatsIndividualInfarctionInjectionsInjuryInsulinInsulin ResistanceInvestigationKnowledgeLacunar InfarctionsLeadLearningLifeMeasuresMemoryMetabolicMicrovascular DysfunctionMissionModelingNatureNeuronsOligodendrogliaOutcomePathologyPerfusionPhenotypePreclinical TestingPublic HealthRadialRattusResearchRisk FactorsSensorySeveritiesSpatial DistributionStreptozocinStressStrokeStructureStructure of beta Cell of isletTestingTherapeuticTimeUnited States National Institutes of HealthVascular DiseasesVascular remodelingVisualizationabeta depositionagedanimal imagingarmbehavior testbehavioral outcomebehavioral studyclinically relevantdementia riskdeoxyhemoglobindesigndiabeticdisabilityexperimental studyfield studygait examinationhemodynamicshigh riskhuman diseaseimaging modalityinnovationmotor deficitnon-invasive imagingnoveloptoacoustic tomographyphysically handicappedpreventtherapeutic evaluationvascular cognitive impairment and dementiavascular injurywater maze
项目摘要
Vascular cognitive impairment and dementia (VCID) is the second most common form of dementia after
Alzheimer’s Disease (AD). VCID is one of the consequences of cerebral small-vessel disease (SVD). This vascular
disorder produces cerebral perfusion deficits and, ultimately, cortical and/or subcortical lacunar strokes. Lacunar
strokes can be ischemic or microhemorrhagic in nature and can result in long-term physical disabilities and death.
Critical to the current proposal, lacunar strokes are a leading cause of VCID. Hypertension, hyperhomocysteinemia,
diabetes and advanced age are independent, major risk factors for SVD and the resulting lacunar strokes. These
factors are often clustered in individuals with both the highest risk for lacunar strokes and the worst outcomes. The
current proposal is driven by the central hypothesis that combining major human risk factors for SVD in an animal
model produces a synergistic effect that recapitulates the human disease etiology, giving rise to vascular injury that
results in lacunar stokes and ultimately VCID. It is further hypothesized that combining these risk factors facilitates
the coalescence of lacunar strokes and that the resulting augmentation of injury hastens behavioral deficits. In this
study, will use the diet-induced hyperhomocysteinemia model of SVD in aged spontaneously hypertensive rats
(SHR), which also produces an insulin-resistant phenotype. In addition, we will further drive the diabetic phenotype
with 1) a high-fructose diet and 2) promoting a reduction in pancreatic beta cells through the use of the low-dose
streptozocin. The superimposition of diabetes will further test our hypothesis that by combining a greater number of
independent risk factors the progression of SVDlacunar infarcts VCID is accelerated and exacerbated. Our
study will also leverage the use a novel, non-invasive imaging modality, multispectral optoacoustic tomography
(MSOT), to identify and measure regions of perfusion/oxygenation deficits and correlate these with behavioral
outcomes longitudinally and with final histological analysis of structural injury. Successful completion of this proposal
will demonstrate that the combination of these risk factors recapitulates human sequelae of SVDlacunar
infarctsVCID in an animal model. Ultimately, the development of this robust and highly relevant lacunar
stroke/VCID animal model and imaging technique will permit pre-clinical testing of targets and lead compounds for
lacunar stroke and VCID therapeutics. We plan to test our central hypothesis and accomplish our overall objective
by pursuing the following Specific Aims: 1) Aim 1: Determine the synergistic effect of hypertension, diet-induced
hyperhomocysteinemia, and aging on small-vessel disease, lacunar strokes and VCID in rats, and 2) Determine the
impact of insulin-resistance and diabetes on lacunar strokes and VCID in a rat model of hypertension-
hyperhomocysteinemia-aging. The proposed research is innovative because it represents a substantial departure
from the status quo by shifting focus onto the investigation of how combining multiple human lacunar stroke and
VCID risk factors that 1) promote vascular remodeling and 2) physically stress the microvasculature can recapitulate
the human condition and result in acceleration and exacerbation of injury in an animal model.
血管性认知障碍和痴呆(VCID)是仅次于老年痴呆症的第二常见形式
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAVIER CUEVAS其他文献
JAVIER CUEVAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAVIER CUEVAS', 18)}}的其他基金
Cytosolic and Plasma Membrane Circuitry of Beta Cell Redox Control: Role in Survival, Oxidative Defense and Insulin Secretion
β 细胞氧化还原控制的胞浆和质膜电路:在生存、氧化防御和胰岛素分泌中的作用
- 批准号:
9285794 - 财政年份:2015
- 资助金额:
$ 41.11万 - 项目类别:
NICOTINIC RECEPTORS IN MAMMALIAN INTRACARDIAC NEURONS
哺乳动物心内神经元中的烟碱受体
- 批准号:
2897350 - 财政年份:1999
- 资助金额:
$ 41.11万 - 项目类别:
NICOTINIC RECEPTORS IN MAMMALIAN INTRACARDIAC NEURONS
哺乳动物心内神经元中的烟碱受体
- 批准号:
6390472 - 财政年份:1999
- 资助金额:
$ 41.11万 - 项目类别:
NICOTINIC RECEPTORS IN MAMMALIAN INTRACARDIAC NEURONS
哺乳动物心内神经元中的烟碱受体
- 批准号:
6184700 - 财政年份:1999
- 资助金额:
$ 41.11万 - 项目类别:
相似海外基金
I-Corps: Translation Potential of Peptidic Ensembles as Novel Bio-adhesives
I-Corps:肽整体作为新型生物粘合剂的转化潜力
- 批准号:
2409620 - 财政年份:2024
- 资助金额:
$ 41.11万 - 项目类别:
Standard Grant
Architectural design of active adhesives
活性粘合剂的结构设计
- 批准号:
2403716 - 财政年份:2024
- 资助金额:
$ 41.11万 - 项目类别:
Standard Grant
Design of non-swellable adhesives for brain surgery using cyclodextrin inclusion polymer
使用环糊精包合物聚合物脑外科不可溶胀粘合剂的设计
- 批准号:
23H01718 - 财政年份:2023
- 资助金额:
$ 41.11万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Meta-material adhesives for improved performance and functionalisation of bondlines
超材料粘合剂可提高粘合层的性能和功能化
- 批准号:
EP/W019450/1 - 财政年份:2023
- 资助金额:
$ 41.11万 - 项目类别:
Fellowship
Light-propelled dental adhesives with enhanced bonding capability
具有增强粘合能力的光驱动牙科粘合剂
- 批准号:
10741660 - 财政年份:2023
- 资助金额:
$ 41.11万 - 项目类别:
DMREF: Accelerating the Design of Adhesives with Nanoscale Control of Thermomechanical Properties
DMREF:通过热机械性能的纳米级控制加速粘合剂的设计
- 批准号:
2323317 - 财政年份:2023
- 资助金额:
$ 41.11万 - 项目类别:
Continuing Grant
Mag-Cure: A novel method for magnetically induced bonding and de-bonding of thermoset adhesives in the Automotive Industry
Mag-Cure:汽车行业中热固性粘合剂磁感应粘合和脱粘的新方法
- 批准号:
10062336 - 财政年份:2023
- 资助金额:
$ 41.11万 - 项目类别:
Collaborative R&D
Biodegradable, Biocompatible Pressure Sensitive Adhesives
可生物降解、生物相容性压敏粘合剂
- 批准号:
10677869 - 财政年份:2022
- 资助金额:
$ 41.11万 - 项目类别:
Poly(glycerol carbonate) pressure sensitive adhesives for the in vivo closure of alveolar pleural fistulae
用于体内闭合肺泡胸膜瘘的聚(甘油碳酸酯)压敏粘合剂
- 批准号:
10746743 - 财政年份:2022
- 资助金额:
$ 41.11万 - 项目类别:
Enhanced bio-production of difficult to make peptide ingredients for specialty adhesives and personal care
增强用于特种粘合剂和个人护理品的难以制造的肽成分的生物生产
- 批准号:
10021363 - 财政年份:2022
- 资助金额:
$ 41.11万 - 项目类别:
Investment Accelerator